Financials

  • Market Capitalization 85.5468 M
  • Employee 13
  • Founded 2018
  • CEO N/A
  • Website www.maiabiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG0113Q7J88
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

MAIA Biotechnology Inc

MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.

Nouvelles